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Abstract
Phorbol ester (TPA) treatment of human U937 myeloid leukemia cells is associated with increasing adherence and
monocyte-like maturation whereby the role of b2 integrin-mediated attachment for subsequent growth properties
and the differentiation program remains unclear. Here, stably-transfected U937 cells with a pMTH1 vector
containing the b2 integrin gene of CD11b in antisense orientation (asCD11b-U937) demonstrated a significantly
reduced proliferative capacity in contrast to control vector transfectants (pMTH1-U937) or wild-type U937 cells.
Phorbol ester exposure induced adherence and growth arrest in more than 90% of pMTH1-U937 and wild-type
U937 cells after 72 h. In contrast, TPA-treated asCD11b-U937 failed to attach and the proliferation continued in
more than 30% of the cells. Moreover, increased apoptosis appeared in asCD11b-U937 after TPA induction in
contrast to pMTH1-U937 cells. In addition, non-specific inhibition of adherence on an agarose surface
demonstrated internucleosomal DNA fragmentation in both, pMTH1-U937 and asCD11b-U937 after TPA treatment
indicating a functional relationship between abolished adherence, regulation of proliferation and induction of
apoptosis. Western blot analysis revealed differences in the expression levels and altered phosphorylation patterns
of Pyk-2, pp60src and p42/p44 MAP kinases between pMTH1-U937 and asCD11b-U937 following TPA exposure
which was also substantiated by Pyk-2 immunoprecipitation. These findings suggested that induced adherence
predominantly mediated by a functional CD11b/CD18 integrin in U937 cells is involved in the activation of
downstream signaling kinases and contributes to cell cycle regulation and apoptosis during monocytic maturation.
Introduction
Human myeloid leukemia cells represent an experimental
model for a monocyte/macrophage-like maturation [1,2]
and effects of differentiation-inducing agents on cell
adherence and filament expression have been extensively
characterized in previous studies [3]. Non-adherent and
autonomously proliferating myeloid leukemia cells
including the human U937 cell line can be induced to
differentiate along the monocyte/macrophage pathway
following stimulation with the phorbol ester derivate 12-
O-tetradecanoyl-phorbol-13-acetate (TPA). Whereas
TPA activates the Ca
2+ and phospholipid-dependent iso-
forms of protein kinase C, the course of TPA-induced
macrophage-like differentiation in U937 cells is also
accompanied by changes in the cAMP metabolism and
cAMP is known to regulate important intracellular sig-
naling processes [4]. Morphological changes of differen-
tiating U937 cells are accompanied by cellular adherence
and these effects are paralleled by an enhanced expres-
sion of the b2 integrins CD11a, CD11c, CD18, and parti-
cularly CD11b [5]. The CD11a, CD11b and CD11c
glycoproteins represent the a-subunits of a heterodimeric
association with the common b-subunit CD18, respec-
tively, to build a functional b2 integrin which are involved
in two different cellular mechanisms of adherence: 1)
adhesion to solid surfaces such as plastic and 2) adhesion
to adjacent cells. Thus, previous work has demonstrated
that a polyphenol-mediated up-regulation of CD11b in
certain T cell subsets resulted in an increased adherence
to plastic, whereas a down-modulation of CD11b in
monocytes was associated with significantly reduced
attachment to the plastic surface [6]. For adhesion to
adjacent cells during the formation of cell-to-cell con-
tacts and intercellular communication processes, junc-
tional adhesion molecules can associate through their
extracellular domains with the CD11b/CD18 (CR3/Mac-
1) b2 integrin contributing for example to the regulation
of leukocyte-endothelial cell interactions [7]. * Correspondence: hass.ralf@mh-hannover.de
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U937 cell line, termed TUR (TPA-U937-resistant), have
demonstrated that this population fails to express signifi-
cant levels of CD11b after TPA treatment [8]. The TUR
have been characterized for a defect to relay a sufficient
threshold of phosphorylation signals downstream of
Raf-1 kinase whereby previous work emphasized the
importance of Raf-1 kinase in the regulation of cellular
proliferation and differentiation [9]. Whereas the kinase
signalling defects in the TUR leukemia cells are likely to
be associated with the proliferative capacity, confirmative
studies in colorectal cancer cells have demonstrated that
high Erk activity can effect cell growth by targeting cell
cycle regulators such as p27
kip1 [10]. In association with
the Raf-1 signaling defect, the human TUR leukemia cells
are unable to attach and continue to proliferate in
response to a phorbol ester stimulation [11] indicating a
functional contribution of CD11b to these effects beyond
the involvement in the regulation of cell attachment.
Indeed, b2 integrin-mediated signalling pathways may
also affect components involved in the extracellular
matrix formation substantiating the importance of a
tumor cell microenvironment [12].
Other studies have demonstrated that a down-modula-
tion of the CD11b integrin fails to develop certain mar-
kers of a monocytic phenotype following exposure to the
differentiation-inducing TPA [13]. However, little is
known about the role of CD11b within the monocytic
differentiation program and how CD11b integrin-
mediated cell attachment may also affect restructure of
the extracellular matrix and a possible involvement in the
cell cycle progression and intracellular metabolic path-
ways which are also relevant for maturation along the
monocytic lineage.
In the present study, it was of interest therefore, to
examine the role of the CD11b integrin and cell adher-
ence for metabolic changes and the proliferative capacity
after phorbol ester treatment of these human leukemic
cells.
Material and methods
Cell culture
Human U937 myeloid leukemia cells (American Type
Culture Collection #CRL-1593.2) were cultured in RPMI
1640 containing 10% of heat-inactivated fetal bovine
serum, 100 units/ml penicillin, 100 μg/ml streptomycin,
and 2 mM L-glutamine in a 37°C humidified atmosphere
with 5% CO2. Moreover, U937 cells stably transfected with
the pMTH1 vector (pMTH1-U937) and U937 cells stably
transfected with the pMTH1 vector containing the CD11b
gene in antisense orientation (asCD11b-U937) [13] were
cultured under similar conditions. The functionality of the
CD11b down-modulation has been demonstrated by
CD11b immunofluorescence staining [13]. The different
cell populations were incubated with 5nM of the differen-
tiation-inducing agent 12-O-tetradecanoylphorbol-13-
acetate (TPA) (Sigma Chemie GmbH, Taufkirchen, Ger-
many) for different time points as indicated.
Cell cycle analysis
The cell cycle analysis and ViCell analysis was performed
as described previously [14]. Briefly, 5 × 10
5 U937 cells,
pMTH1-U937 control or asCD11b-U937 were exposed
to 5 nM TPA for 24 h, 48 h and 72 h, respectively. Fol-
lowing incubation, the different populations were fixed in
70% (v/v) ice-cold ethanol at 4°C for 24 h. Thereafter, the
fixed cells were stained with CyStain DNA 2 step kit
(Partec GmbH, Münster, Germany) and filtered through
a5 0μm filter. The samples were then analyzed in a
Galaxy flow cytometer (Partec) using the MultiCycle cell
cycle software (Phoenix Flow Systems Inc., San Diego,
CA). The subG1 population which represents dying or
dead cells was calculated as the rate of apoptotic cells.
Apoptosis assay
Following an appropriate 24 h TPA treatment in the
presence or absence of an agarose surface, 1 × 10
6
pMTH1-U937 control cells and asCD11b-U937 cells
were harvested by centrifugation, washed with PBS and
incubated in 20 μl of 50 mM Tris-HCL (pH 8.0), 10 mM
EDTA, 0.5% SDS, and 0.5 μg/ml proteinase K (Sigma
Chemical GmbH) for 1 h at 50°C, respectively. There-
after, 10 μlo f0 . 5μg/ml (DNase free) RNase was then
added and the incubation continued for an additional
hour. The digested samples were incubated with 10 μl
of 10 mM EDTA (pH 8.0) containing 2% (w/v) low-
melting-point agarose, 0.25% bromophenol blue, and
40% (w/v) sucrose at 70°C. The DNA was separated in a
2% agarose gel according to a DNA base pair (bp) length
marker and visualized by UV illumination after ethidium
bromide staining.
Immunoblot analysis
Untreated and 5 nM TPA-stimulated pMTH1-U937 and
asCD11b-U937 cells were washed three times in ice-cold
PBS and lysed in a buffer containing 10 mM Tris-HCl (pH
7.6), 140 mM NaCl, 10 mM EDTA, 1% (v/v) NP-40 with
the addition of 10 μg/ml aprotinin, 10 μg/ml leupeptin,
and 1 mM phenylmethylsulfonylfluoride (PMSF) (all from
Sigma). Protein concentration of the cell lysates was
adjusted using the colorimetric BCA-assay (Perbio Science
Deutschland, Bonn, Germany), subjected to SDS-polyacry-
lamide gel electrophoresis and transferred to a PVDF
membrane (Millipore GmbH, Schwalbach, Germany). The
membranes were blocked with PBS containing 5% FCS
and 0.05% Tween-20 (PBS/Tween). After washing four
times with PBS/Tween, the membranes were incubated
with the primary antibodies (polyclonal anti-c-Jun (Geneka
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p21
WAF-1/sdi-1, clone SX118 (BD Biosciences, Heidelberg,
Germany); monoclonal anti-vimentin, clone VIM 13.2
(Sigma Chemie GmbH, Taufkirchen, Germany); polyclonal
anti-caspase-3, cleaved at Asp175 (Cell Signaling Technol-
ogies, Danvers, MA, USA) monoclonal anti-FAK, clone 77
(BD Biosciences, Heidelberg, Germany); polyclonal anti-
Pyk-2 (Biomol GmbH, Hamburg, Germany); pp60src,
polyclonal anti phopho pp60src (Tyr
416) (NEB/Cell Signal-
ing Technology, Frankfurt/Main, Germany), MAP kinase,
monoclonal anti-phospho-p44/42 MAP kinase, clone E10
(NEB/Cell Signaling Technologies) and monoclonal anti-
b-actin, clone C4/actin (BD Biosciences), for 2 h/37°C,
washed four times with PBS/Tween and incubated with
the appropriate horseradish peroxidase-conjugated sec-
ondary antibody (all from Santa Cruz Biotechnology,
Santa Cruz, CA) for 1 h/37°C. The membranes were
washed with PBS/Tween and visualized by autoradiogra-
phy using the ECL-detection kit (GE Healthcare,
München, Germany).
Immunoprecipitation of Pyk-2
After swelling and washing of protein-A sepharose CL-4B
(GE Healthcare, München, Germany) in PBS according to
the manufacturer’s instructions, the resuspended sephar-
ose was coupled with an anti-Pyk-2 antibody (Santa Cruz
Biotechnology Inc., Heidelberg, Germany) for 1 h at 4°C.
In parallel, cell lysates from untreated and 5 nM TPA-
stimulated pMTH1-U937 and asCD11b-U937 cells were
adjusted to similar protein amounts according to the
BCA-assay and pre-absorbed to uncoupled sepharose for
1 h at 4°C. Following centrifugation (14,000 g/5 min) and
removal of the sepharose beads, the pre-absorbed cell
lysates were incubated with the anti-Pyk-2-coupled
sepharose for 2 h at 4°C. After 5× washing in RIPA-buffer,
the sepharose beads carrying the immunoprecipitates were
subjected to a SDS-polyacrylamide gel electrophoresis and
transferred to a PVDF membrane (Millipore GmbH).
Subsequent Western blotting was performed by using a
polyclonal anti-Pyk-2 antibody (Biomol GmbH) and a
monoclonal anti-phophotyrosine antibody, clone 4G10
(Upstate Inc., Lake Placid, NY, USA) and the blots were
visualized by autoradiography using the ECL-detection kit
(GE Healthcare).
Results
The proliferative capacity of pMTH1-U937 and asCD11b-
U937 cells was measured after induction of differentiation
with 5 nM TPA providing either plastic adherence in nor-
mal culture dishes (uncoated plates) or the culture onto a
layer of 2% agarose to non-specifically block cell-to-sub-
strate adherence (Figure 1). Thus, pMTH1-U937 cells
demonstrated a continuously increasing proliferation
whereby TPA treatment resulted in a significant growth
arrest after 72 h (Figure, 1A). These proliferative and mor-
phological findings were in absolute agreement with data
obtained from wild-type U937 cells [5]. In contrast,
asCD11b-U937 transfectants exhibited a significantly
reduced steady-state proliferation as compared to pMTH1-
U937 both, in uncoated and agarose-coated plates (Figure
1A, B). Moreover, incubation of asCD11b-U937 with 5 nM
TPA transiently slowed the cell growth to about 30% of the
cells in contrast to a marked growth inhibition of more
Figure 1 Quantification of viable cells in TPA-treated pMTH1-
U937 and asCD11b-U937 cultures. A. The pMTH1-U937 and
asCD11b-U937 cells were incubated in 24-well plates at a density of
5×1 0
4 cells/ml in the absence or presence of 5 nM TPA for up to
72 h, respectively. The number of viable cells in the different
populations was measured by trypan blue exclusion. Adherent cells
were detached for cell counting by Trypsin/EDTA treatment. Data
represent the mean ± s.d. of four independent experiments.
Statistical significance was evaluated by paired student’s t-test (p <
0.005 (*); p < 0.001 (**)) for the comparison of untreated and
corresponding TPA-treated populations. B. The pMTH1-U937 and
asCD11b-U937 cells were cultured at a density of 5 × 10
4 cells/ml in
24-well plates precoated with 2% agarose to non-specifically block
cellular adherence. Following incubation in the absence or presence
of 5 nM TPA for up to 72 h, the number of viable cells in the
different populations was measured by trypan blue exclusion. Data
represent the mean ± s.d. of four independent experiments.
Statistical significance was evaluated by paired student’s t-test (p <
0.005 (*); p < 0.001 (**)) for the comparison of untreated and
corresponding TPA-treated populations.
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(Figure 1A). In addition, asCD11b-U937 population
reduced the cell viability and showed little if any cell adhe-
sion in either uncoated or agarose-coated plates following
exposure to the phorbol ester (data not shown).
With respect to the morphology, proliferating pMTH1-
U937 as single cells in normal culture dishes exhibited
both, a cell-to-cell and a cell-to-matrix (e.g. plastic)
adherence by the formation of firmly-attached three-
dimensional cell aggregates after 72 h of TPA exposure
which has been similarly documented in TPA-treated
U937 cells [5]. Following culture of pMTH1-U937 on an
agarose surface, the formation of three-dimensional cell
aggregates could be observed again after phorbol ester
incubation, however, these cell aggregates were floating
in suspension and failed to attach to the matrix. More-
over, this TPA-induced pMTH1-U937 population on
agarose-coated culture dishes demonstrated a variety of
disintegrated and dead cells after 72 h (data not shown).
Likewise, TPA-treated asCD11b-U937 transfectants
revealed numerous disintegrated and dead cells after
TPA exposure, however, this accumulation of cell death
was already observed in normal culture dishes and did
not significantly alter in the presence of agarose (data not
shown).
According to the altered morphology and proliferation
in the different populations cell cycle analysis was per-
formed to evaluate changes in the cell cycle distribution
(Figure 2). Wild-type U937 and pMTH1-U937 cells
showed similar distributions displaying a loss of S phase
cells from about 20% down to about 2% and a significant
accumulation in G0/G1 phase from about 58% up to more
than 70% within 72 h of TPA treatment (Figure 2). In con-
trast, asCD11b cells continuedt op r o g r e s si n t oSp h a s e
after TPA exposure which remained at about 12% (Figure
2). Moreover, a progressive accumulation of apoptotic
subG1 cells became detectable in asCD11b cells ranging
from less than 2% in the untreated population to more
than 70% after 72 h of TPA exposure (Figure 2).
These findings indicated that together with the failed
attachment after TPA treatment, the asCD11b-U937 cells
remain in the proliferative cell cycle which may lead to
apoptosis. Indeed, analysis of internucleosomal DNA frag-
mentation as one marker for apoptosis revealed little if
any detectable DNA fragments in untreated pMTH1-
U937 and asCD11b-U937 cells, as well as in the 24 h
TPA-exposed pMTH1-U937 population in uncoated cul-
ture dishes (Figure 3). However, in agarose-coated dishes,
the 24 h TPA-treated pMTH1-U937 demonstrated signifi-
cant DNA laddering according to the DNA base pair stan-
dard which was paralleled by 24 h TPA-treated asCD11b
populations independent of uncoated or agarose-coated
dishes (Figure 3). Together, these findings suggested that
TPA-treated U937 cells allowed for cell attachment cease
to divide and progress with a differentiation program. In
contrast, TPA-treated U937 cells with an abolished cell
attachment underwent apoptosis indicating that the adher-
ence-associated b2 integrin CD11b may play a significant
role in mediating signals for the regulation of proliferation
and differentiation.
In order to further test the hypothesis of differentiation
defects and functional alterations due to the down-modu-
lation of the CD11b integrin, Western blot analysis was
applied to differentiation markers, kinase expression and
metabolic factors. Whereas TPA treatment of pMTH1-
U937 cells was associated with a significant induction of
the c-Jun protein within 72 h, little if any induction of this
transcription factor was detectable in asCD11b-U937 cells
(Figure 4). Likewise, the cell cycle inhibitor p21
sdi-1 and
the differentiation marker vimentin were significantly
expressed after TPA exposure of pMTH1-U937 cells in
contrast to asCD11b-U937 cells (Figure 4). For the detec-
tion of apoptosis products, cleaved fragments (17/19 kDa)
of caspase-3 were detectable exclusively in TPA-treated
asCD11b-U937 cells with a significant increase between
24 h to 48 h (Figure 4).
Signaling compounds for b2 integrins involve p125
focal adhesion kinase (FAK) and the 112 kDa Pyk-2
kinase. Whereas little FAK expression was detectable in
the different populations, Pyk-2 protein levels were
slightly enhanced in pMTH1-U937 cells as compared to
asCD11b-U937 cells following phorbol ester stimulation
(Figure 4). Likewise, tyrosine phosphorylation of Pyk-2 as
determined in immunoprecipitation experiments was
progressively elevated in pMTH1-U937 cells in contrast
to asCD11b-U937 after TPA exposure for 24 h to 72 h
(Figure 5). Downstream signaling kinases including
pp60
src and the p42/p44 MAP kinases revealed a more
pronounced protein expression of these kinases in TPA-
treated asCD11b-U937 rather than pMTH1-U937 cells
(Figure 4). Conversely, with respect to the signalling
pMTH1-U937 cells demonstrated an enhanced phos-
phorylation of p42/p44 MAP kinases and phopho pp60
src
(P-Tyr
416) between 24 h and 72 h after TPA exposure as
compared to asCD11b-U937 cells (Figure 4).
Discussion
Phorbol ester treatment of non-adherent human myeloid
leukemia cells is associated with cell attachment to form
3-dimensional cell aggregates, growth arrest and mono-
cytic differentiation, and conversely, the reversible pro-
cess of retrodifferentiation and rejuvenation reveals the
loss of previously acquired monocytic features, a regained
proliferative capacity and cell detachment to form again a
single cell suspension of monoblastoid precursor cells
[3,15]. Whereas these findings suggested a tight regula-
tory relationship between adherence, cell growth and
metabolic changes, previous work has documented a
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Page 4 of 9Figure 2 Cell cycle analysis of U937, pMTH1-U937 and asCD11b-U937 cells. U937 cells, pMTH1-U937 and asCD11b-U937 cells were
incubated in 6-well plates at a density of 5 × 10
4 cells/ml in the absence or presence of 5 nM TPA for up to 72 h, respectively. At the time
points indicated representative aliquots of each population were fixed in 70% ethanol, stained with a CyStain DNA kit and subjected to cell cycle
analysis by flow cytometry. The percentage of cell cycle distribution was gated and calculated using the Multi-cycle software.
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induced adherence of human leukemic cells [5]. This
function of CD11b appears even more pronounced by its
involvement to affect the cell growth as indicated by the
significantly reduced cell number after down-modulation
of CD11b. TPA exposure further diminished the persist-
ing growth activity in asCD11b cells, however, the
amount of viable cells remained significantly higher after
72 h as compared to a complete growth arrest in control
transfectants suggesting a functional role b2 integrins in
the balance of adherence and the regulation of U937 cell
growth. This hypothesis is also substantiated by the non-
specific inhibition of adherence in the agarose-coated
plates after 72 h of TPA treatment, whereby the amount
of asCD11b cells remained at a similar level as compared
to pMTH1 control transfectants which were unable to
adhere to the agarose surface. Moreover, the steady-state
proliferation on agarose without phorbol ester exposure
already demonstrates differences in the proliferative
capacity between pMTH1 control U937 cells and
asCD11b transfectants suggesting regulatory effects by b2
integrins on the U937 cell growth independent of TPA-
mediated differentiation signals.
Following TPA-induced adherence and subsequent dif-
ferentiation pMTH1 control transfectants like wild-type
U937 cells arrested predominantly in G0/G1 of the cell
Figure 3 Analysis of apoptosis by internucleosomal DNA
fragmentation. Untreated pMTH1-U937 (pMTH1 control) and
untreated asCD11b-U937 (asCD11b control) were incubated with 5
nM TPA at a density of 5 × 10
4 cells/ml either in uncoated or in 2%
(w/v) agarose-precoated cell culture dishes for 24 h, respectively.
Following DNA extraction the samples were analyzed in a 2%
agarose gel and visualized by UV illumination after ethidium
bromide staining. The cell cycle histograms were analyzed in the
Flomax program (Partec) and the percentage of the distinct cell
cycle phase has been calculated using the MultiCycle cell cycle
software (Phoenix Flow Systems Inc., San Diego, CA).
Figure 4 Western blot analysis. The pMTH1-U937 (pMTH1) and
asCD11b-U937 (asCD11b) cells were cultured in the absence and in
the presence of 5 nM TPA for 24 h up to 72 h, respectively.
Thereafter, the different populations were harvested, lyzed and 40
μg of total cellular protein was. For the expression of growth and
differentiation markers, antibodies against p21, c-Jun and vimentin
were applied. Kinase expression was tested for FAK, PYK-2, pp60
src
and MAP kinase, respectively. The unaltered expression level of b-
actin serves as a loading control.
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p21
sdi-1 in contrast to asCD11b-U937 cells displaying a
progressive accumulation of a non-attached population
in the subG1 phase with characteristics of apoptosis. The
importance of attachment for subsequent differentiation
in these cells is also substantiated in TPA-treated
pMTH1 on agarose whereby the failure of matrix adher-
ence resulted in apoptosis despite of a significant CD11b
induction. Taken together, these findings suggest that a
sufficient expression of b2 integrins in differentiating
U937 cells represents a prerequisite for subsequent
matrix adherence-mediated growth arrest and a func-
tional monocytic maturation program. Conversely,
down-modulation of b2 integrins abrogated the cell
adherence and consequently, continuing proliferation sig-
nals can interfere with and derail the concomitant induc-
tion of factors associated with the monocytic phenotype
eventually resulting in apoptosis as indicated by DNA
fragmentation and caspase-3 cleavage.
A functional b2 integrin composition in monocytic cells
is involved in adhesion, transendothelial migration and
phagocytosis [16] and it can relay downstream signals for
cell polarity via the small Rho GTPase Cdc42 in neutro-
phils [17], however, the detailed signalling mechanisms of
the b2 integrins via downstream kinases to contribute to a
regulatory balance between adhesion-mediated cell cycle
progression and a paralleled differentiation program
remain unclear.
Integrin signalling-mediated cellular activation predomi-
nantly involves focal adhesion kinase (FAK) and related
adhesion focal tyrosine kinase (RAFTK), also known as
cell adhesion kinase-ß (CAK-ß) or proline-rich tyrosine
kinase (Pyk) 2 [18]. b2-integrin-mediated activation of
FAK is associated with autophosphorylation and a transi-
ent downstream activation of SH2 adaptor proteins such
as Grb2 and kinases including phosphatidylinositol-3-
k i n a s ea n dd i s t i n c ts r ck i n a ses. Pyk-2 can regulate cell
spreading and migration after CD11b/CD18-controlled
adhesion [19]. Whereas signalling cascades relayed by
FAK, Pyk-2, pp60
src and MAP kinase are conferred via
phosphorylation at Ser/Thr and/or Tyr residues, the pre-
sent study indicated that the significantly reduced thresh-
old of phosphorylation signals in phorbol ester-induced
asCD11b-U937 as compared to the pMTH1-U937 control
transfectants may be insufficient to relay stable down-
stream signals for growth arrest and differentiation. This
hypothesis is further substantiated by the elevated protein
levels of pp60
src and MAP kinase in asCD11b-U937 after
TPA stimulation suggesting that the increased expression
of downstream kinases cannot compensate the failure of a
required upstream signal to relay an adequate threshold of
phosphorylation signals.
Figure 5 Immunoprecipitation of Pyk-2. The pMTH1-U937 (pMTH1) and asCD11b-U937 (asCD11b) cells were cultured in the absence and in
the presence of 5 nM TPA for 24 h up to 72 h, respectively. Thereafter, the different populations were harvested, lyzed and after pre-absorbation
incubated with sepharose-conjugated anti-Pyk-2. Precipitated Pyk-2 samples (IP Pyk-2) were then separated by 10% SDS-PAGE followed by
Western blotting for Pyk-2 equal loading and for Pyk-2 phosphorylation by phosphotyrosine (P-Tyr).
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tern, inhibition of CD11b/CD18-mediated adherence also
affects the expression levels of the kinases during TPA-
induced differentiation suggesting much more profound
alterations in the overall cell function and fate since phos-
phorylation signals can be adapted and changed much
faster than a kinase protein expression profile.
Recent data in murine macrophages demonstrated a
CD11b/CD18-dependent expression of pro-inflammatory
cytokines via activation of FAK/PI3K/Akt/NF-kappaB
signaling pathways [20]. Other work has also demon-
strated that activation and clustering of the aMb2 integ-
rin in U937 cells and peripheral blood monocytes
induced a translocation of PKCδ t ot h ep l a s m am e m -
brane, whereby PKCδ is phosphorylated and thereby acti-
vated via the src family kinases Hck and Lyn to relay
downstream signals involving the transcription factor
Foxp1 [21]. The importance of PKCδ and associated
MAP kinases during U937 and TUR cell differentiation
and adherence has been demonstrated and suggested a
functional relationship between these kinase systems and
integrin-mediated attachment [22]. Indeed, previous
work has documented the requirement of kinases includ-
ing Src, PKCa, and PKCδ for integrin-mediated invasion
by metastatic melanoma cells [23].
Other functional pathways which substantiate an
involvement of MAP and src kinases in b2 integrin-
relayed downstream signaling include the intracellular
formation of reactive oxygen species which are proper-
ties of monocytes or activated macrophages. Thus, stu-
dies have demonstrated that inhibition of MAP kinases
and the src kinase family blocked CD11b/CD18-
mediated superoxide anion generation [24]. Thus, the
enhanced expression of MAP kinase and pp60
src pro-
teins in asCD11b cells as compared to pMTH1 control
transfectants may elevate the TPA-induced superoxide
anion production [25,26] due to the reduced availability
of sufficient CD11b/CD18 protein complexes.
In summary, these findings suggested an important role
of the functional b2 integrins to coordinate cell growth
with signals for a monocytic maturation of U937 cells.
Thus, a disturbed interaction with the cellular microen-
vironment by an abolished adherence can result in
appropriate regulatory imbalances and subsequent
apoptosis.
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